Cargando…
Infection with Wild Type SARS-CoV-2 Combined with Vaccination Augments Neutralizing Antibody Levels Against Variants Including Omicron
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Mosby, Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895900/ http://dx.doi.org/10.1016/j.jaci.2022.12.079 |
| _version_ | 1784881946475626496 |
|---|---|
| author | O’Shea, Daniel Schuler, Charles Chen, Jesse Troost, Jonathan Wong, Pamela Chen, Kelsea Peng, Westley Gherasim, Carmen Manthei, David Valdez, Riccardo Baldwin, James O'Shea, Kelly Baker, James |
| author_facet | O’Shea, Daniel Schuler, Charles Chen, Jesse Troost, Jonathan Wong, Pamela Chen, Kelsea Peng, Westley Gherasim, Carmen Manthei, David Valdez, Riccardo Baldwin, James O'Shea, Kelly Baker, James |
| author_sort | O’Shea, Daniel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9895900 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Published by Mosby, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98959002023-02-06 Infection with Wild Type SARS-CoV-2 Combined with Vaccination Augments Neutralizing Antibody Levels Against Variants Including Omicron O’Shea, Daniel Schuler, Charles Chen, Jesse Troost, Jonathan Wong, Pamela Chen, Kelsea Peng, Westley Gherasim, Carmen Manthei, David Valdez, Riccardo Baldwin, James O'Shea, Kelly Baker, James J Allergy Clin Immunol Article Published by Mosby, Inc. 2023-02 2023-02-03 /pmc/articles/PMC9895900/ http://dx.doi.org/10.1016/j.jaci.2022.12.079 Text en Copyright © 2022 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article O’Shea, Daniel Schuler, Charles Chen, Jesse Troost, Jonathan Wong, Pamela Chen, Kelsea Peng, Westley Gherasim, Carmen Manthei, David Valdez, Riccardo Baldwin, James O'Shea, Kelly Baker, James Infection with Wild Type SARS-CoV-2 Combined with Vaccination Augments Neutralizing Antibody Levels Against Variants Including Omicron |
| title | Infection with Wild Type SARS-CoV-2 Combined with Vaccination Augments Neutralizing Antibody Levels Against Variants Including Omicron |
| title_full | Infection with Wild Type SARS-CoV-2 Combined with Vaccination Augments Neutralizing Antibody Levels Against Variants Including Omicron |
| title_fullStr | Infection with Wild Type SARS-CoV-2 Combined with Vaccination Augments Neutralizing Antibody Levels Against Variants Including Omicron |
| title_full_unstemmed | Infection with Wild Type SARS-CoV-2 Combined with Vaccination Augments Neutralizing Antibody Levels Against Variants Including Omicron |
| title_short | Infection with Wild Type SARS-CoV-2 Combined with Vaccination Augments Neutralizing Antibody Levels Against Variants Including Omicron |
| title_sort | infection with wild type sars-cov-2 combined with vaccination augments neutralizing antibody levels against variants including omicron |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895900/ http://dx.doi.org/10.1016/j.jaci.2022.12.079 |
| work_keys_str_mv | AT osheadaniel infectionwithwildtypesarscov2combinedwithvaccinationaugmentsneutralizingantibodylevelsagainstvariantsincludingomicron AT schulercharles infectionwithwildtypesarscov2combinedwithvaccinationaugmentsneutralizingantibodylevelsagainstvariantsincludingomicron AT chenjesse infectionwithwildtypesarscov2combinedwithvaccinationaugmentsneutralizingantibodylevelsagainstvariantsincludingomicron AT troostjonathan infectionwithwildtypesarscov2combinedwithvaccinationaugmentsneutralizingantibodylevelsagainstvariantsincludingomicron AT wongpamela infectionwithwildtypesarscov2combinedwithvaccinationaugmentsneutralizingantibodylevelsagainstvariantsincludingomicron AT chenkelsea infectionwithwildtypesarscov2combinedwithvaccinationaugmentsneutralizingantibodylevelsagainstvariantsincludingomicron AT pengwestley infectionwithwildtypesarscov2combinedwithvaccinationaugmentsneutralizingantibodylevelsagainstvariantsincludingomicron AT gherasimcarmen infectionwithwildtypesarscov2combinedwithvaccinationaugmentsneutralizingantibodylevelsagainstvariantsincludingomicron AT mantheidavid infectionwithwildtypesarscov2combinedwithvaccinationaugmentsneutralizingantibodylevelsagainstvariantsincludingomicron AT valdezriccardo infectionwithwildtypesarscov2combinedwithvaccinationaugmentsneutralizingantibodylevelsagainstvariantsincludingomicron AT baldwinjames infectionwithwildtypesarscov2combinedwithvaccinationaugmentsneutralizingantibodylevelsagainstvariantsincludingomicron AT osheakelly infectionwithwildtypesarscov2combinedwithvaccinationaugmentsneutralizingantibodylevelsagainstvariantsincludingomicron AT bakerjames infectionwithwildtypesarscov2combinedwithvaccinationaugmentsneutralizingantibodylevelsagainstvariantsincludingomicron |